Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Age-related macular degeneration

T Segato1, E Midena, M C Blarzino

  • 1Institute of Ophthalmology, University of Padova, Italy.

Aging (Milan, Italy)
|June 1, 1993
PubMed
Summary

Age-related macular degeneration (AMD) is a leading cause of vision loss in older adults. This review covers AMD

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultra-wide-field fundus photography compared to ophthalmoscopy in diagnosing and classifying major retinal diseases.

Scientific reports·2022
Same author

Microperimetry in age: related macular degeneration.

Eye (London, England)·2017
Same author

Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe.

European journal of cancer (Oxford, England : 1990)·2011
Same author

In vivo confocal microscopy of ocular surface squamous neoplasia.

Eye (London, England)·2011
Same author

Long-term follow-up with optical coherence tomography and microperimetry in eyes with metamorphopsia after macula-off retinal detachment repair.

Eye (London, England)·2010
Same author

Macular automatic fundus perimetry threshold versus standard perimetry threshold.

European journal of ophthalmology·2007

Area of Science:

  • Ophthalmology
  • Geriatrics
  • Medical Research

Background:

  • Age-related macular degeneration (AMD) is a progressive, bilateral macular disease causing significant vision loss in elderly populations.
  • AMD manifests with varying clinical features, from early asymptomatic signs like drusen to advanced atrophic or exudative changes.
  • It is a primary cause of irreversible vision impairment and blindness in Western countries.

Purpose of the Study:

  • To review current epidemiologic, pathogenetic, and clinical data on AMD.
  • To emphasize the critical need for identifying patients at risk of progressing to the exudative form of AMD.
  • To analyze therapeutic strategies for AMD, including the role of laser photocoagulation.

Main Methods:

  • Comprehensive literature review of existing AMD research.
  • Analysis of epidemiological trends and pathogenetic mechanisms.
  • Evaluation of clinical presentations and progression markers.

Main Results:

  • AMD presents a spectrum of disease progression.
  • Early identification of at-risk individuals is crucial for intervention.
  • Therapeutic options, including laser photocoagulation, are discussed in relation to disease stage.

Conclusions:

  • Understanding AMD's progression is key to managing vision loss.
  • Risk stratification aids in targeted therapeutic interventions.
  • Continued research into AMD pathogenesis and treatment is essential.

Related Experiment Videos